Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8

PURPOSE: The purpose of this study is to test the ability of risedronate and estradiol, alone or in combination, to prevent bone loss associated with androgen deprivation therapy in men with prostate cancer. MATERIALS AND METHODS: This is a randomized placebo-controlled trial of risedronate and estr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kearns, Ann E., Northfelt, Donald W., Dueck, Amylou C., Atherton, Pamela J., Dakhil, Shaker R., Rowland, Kendrith M., Fuloria, Jyotsna, Flynn, Patrick J., Dentchev, Todor, Loprinzi, Charles L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2009
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3903398/
https://ncbi.nlm.nih.gov/pubmed/19468757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-009-0655-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados